• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

VMocion secures $3M for virtual motion technology.

Share:

January 9, 2024

VMocion secures $3 million in seed funding with participation from AZ Crown and Mayo Clinic, attracting Insight Enterprises’ Eric Crown to its board. The Arizona-based tech firm’s 3V technologies aim to eradicate motion sickness in extended reality (XR) by stimulating the inner ear’s vestibular system through wearable contact points. Their WAIV algorithm creates a synchronized sense of motion, enhancing XR experiences. VMocion intends to advance its technology with the funding, competing alongside OVR Technology in enhancing XR realism.

VMocion, a technology company focused on allowing users to “feel” the motion they see in extended reality (XR) experiences, announced it secured $3 million in seed funding.

AZ Crown and Mayo Clinic participated in the round.

Eric Crown of Insight Enterprises will join the company’s board of directors.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

WHAT IT DOES

VMocion’s 3V technologies provide users with a sense of physical motion while in extended reality, which includes virtual reality, augmented reality and mixed reality.

The company says its WAIV algorithmic technology eliminates motion sickness, which some users experience while in an extended reality setting, by sending electrical impulses to one’s inner ear via wearable contact points placed on the skin.

The impulses stimulate the ear’s vestibular system, awhich creates a sense of balance and spatial orientation in the human body to coordinate movement with balance.

VMocion says the technology gives users a virtually simulated sense of physical motion that matches what they see on screen.

The Arizona-based company will use the funds to advance its technology.

MARKET SNAPSHOT

Another company working to make extended reality feel more realistic is OVR Technology.

OVR offers ION, its wearable scent technology that utilizes a cartridge that attaches to a virtual reality headset. The cartridge gives off scents, allowing users to experience the smell of the virtual environment.

Source: Mobihealth News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Emory University’s Heart Disease Prediction Study To Use VivaLNK’s Wearable ECG PatchEmory University’s Heart Disease Prediction Study To Use VivaLNK’s Wearable ECG Patch
  • Sunovion and BIAL Enter European Licensing Agreement for Apomorphine Sublingual Film for the Treatment of Parkinson’s Disease OFF EpisodesSunovion and BIAL Enter European Licensing Agreement for Apomorphine Sublingual Film for the Treatment of Parkinson’s Disease OFF Episodes
  • Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc.Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc.
  • OvaScience Shareholders File Lawsuits to Stop Merger With Millendo TherapeuticsOvaScience Shareholders File Lawsuits to Stop Merger With Millendo Therapeutics
  • Nanox and Usard Expand Their Radiology Diagnostic Partnership; Sera Prognostics and Anthem Launch a Neonatal Outcomes Study; and More Digital Health DealsNanox and Usard Expand Their Radiology Diagnostic Partnership; Sera Prognostics and Anthem Launch a Neonatal Outcomes Study; and More Digital Health Deals
  • Navidea Biopharmaceuticals, Inc. Receives $7.5 Million Cash from Cardinal Health in Lieu of Contingent Milestone PaymentNavidea Biopharmaceuticals, Inc. Receives $7.5 Million Cash from Cardinal Health in Lieu of Contingent Milestone Payment
  • Jasper Therapeutics Announces Expansion of Series a Financing, Bringing Total Corporate Fundraising to More Than $50 MillionJasper Therapeutics Announces Expansion of Series a Financing, Bringing Total Corporate Fundraising to More Than $50 Million
  • Scientists create human ‘mini-brain’Scientists create human ‘mini-brain’

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications